muster 发表于 2025-3-23 11:44:57

Independent Biopharmaceutical Companies and their Specialization in Drug Discovery Technologies,Biopharmaceutical companies that are the subject of this study perform

hermitage 发表于 2025-3-23 17:35:14

http://reply.papertrans.cn/32/3119/311807/311807_12.png

眨眼 发表于 2025-3-23 21:51:48

http://reply.papertrans.cn/32/3119/311807/311807_13.png

任命 发表于 2025-3-23 23:09:30

1431-1941 testing different decision-making strategies is developed. For each phase the author identifies decision rules that provide for successful corporate growth..978-3-7908-0033-3978-3-642-57432-0Series ISSN 1431-1941 Series E-ISSN 2197-716X

LATER 发表于 2025-3-24 05:11:35

Understanding the Language Classroomon” refers to the period directly following start-up success until the time the biotechnology firm receives major revenue streams from a portfolio of drugs on the market. The following diagram illustrates, on the highest level of aggregation, the scope and boundaries of the transition model.

低位的人或事 发表于 2025-3-24 08:44:53

http://reply.papertrans.cn/32/3119/311807/311807_16.png

神圣将军 发表于 2025-3-24 14:38:15

http://reply.papertrans.cn/32/3119/311807/311807_17.png

暂停,间歇 发表于 2025-3-24 15:13:52

http://reply.papertrans.cn/32/3119/311807/311807_18.png

adulterant 发表于 2025-3-24 20:27:59

http://reply.papertrans.cn/32/3119/311807/311807_19.png

TATE 发表于 2025-3-25 02:44:55

http://reply.papertrans.cn/32/3119/311807/311807_20.png
页: 1 [2] 3 4
查看完整版本: Titlebook: Entrepreneurship in Biotechnology; Managing for Growth Martin Grossmann Book 2003 Springer-Verlag Berlin Heidelberg 2003 Entrepreneurs.Ent